Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Affinivax Inc. logo — company profile

Affinivax Inc.

Founded 2014 United States Cambridge, United States 23 employees Grant Total: $377.49M Biotechnology, Health Care +1

General Information

Company Name Affinivax Inc.
Founded Year 2014
Location United States Cambridge, United States
Founders / Decision Makers
Team member
Employees 23
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Affinivax Inc.. To contact Affinivax Inc., visit affinivax.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Affinivax Inc.

Affinivax Inc. was acquired by GSK in August 2022. Founded in 2014, the United States-based company operates in the Biotechnology, Health Care, and Pharmaceutical industries. Affinivax is a clinical stage biotechnology company that has received significant investment, with its last round amounting to $22.00M from CARB-X in March 2021. The company is focused on developing a next-generation approach in vaccine technologies, aiming to design preventive and therapeutic vaccines that offer broader protection against infectious and other immune-mediated diseases.

Taxonomy: Affinivax, GSK, Vaccine technologies, Preventive vaccines, Therapeutic vaccines, Infectious diseases, Immune mediated diseases, Clinical stage, Acquisition, Next generation approach, Research and development, Pharmaceuticals, Innovation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $22.00M 1
CARB-X
CARB-X
09 Mar 2021
Series C $226.00M 9
T. Rowe Price Wellington Management EcoR1 Capital
T. Rowe Price, Wellington Management +7
08 Jan 2021
Series B $120.00M -
23 Apr 2020
Venture Round $6.99M -
05 Jan 2018
Series A $2.50M -
05 Feb 2016

Affinivax Inc. Alternatives & Competitors

View All Alternatives
Affinivax Inc. vs
Vaxinano
Vaxinano

Developing life-changing vaccines and immunotherapies

Non Equity Assistance
13 employees
Biotechnology, Pharmaceutical
Affinivax Inc. vs
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. United States

Revolutionizing medicine with precision.

Post-IPO Equity
31 employees
Biotechnology, Health Care
Affinivax Inc. vs
7 Hills Pharma
7 Hills Pharma United States

First-in-concept platform of oral drugs to overcome immunotherapy resistance

Grant
12 employees
Health Care, Pharmaceutical
Also compare with: Affinivax Inc. vs Celularity Inc. Celularity Inc. View all alternatives

FAQ About Affinivax Inc.

Affinivax was acquired by GSK in August 2022. Affinivax is a clinical stage biotechnology company developing a next generation approach in vaccine technologies to design both preventive and therapeutic vaccines that provide broader protection against infectious and other immune mediated diseases.
Affinivax Inc. was founded in 2014.
Affinivax Inc. is headquartered in Cambridge, United States.
Affinivax Inc. operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Affinivax, GSK, Vaccine technologies and Preventive vaccines.
Affinivax Inc. has approximately 23 employees.
Affinivax Inc. has completed 5 funding rounds, raising a total of $377.49M. The latest funding stage is Grant.
Top alternatives and competitors to Affinivax Inc. include Vaxinano, Prometheus Biosciences, Inc., 7 Hills Pharma, OXFORD VACMEDIX UK LIMITED, Rocketvax AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Affinivax Inc. and Vaxinano are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Affinivax Inc., https://bouncewatch.com/company/affinivax-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes